HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Hidiroglou, M. Articles by Ivan, M. Search for Related Content PubMed PubMed Citation Articles by Hidiroglou, M. Articles by Ivan, M.

Pharmacokinetics and Amounts of 25-Hydroxycholecalciferol in Sheep Affected by Osteodystrophy

Research Branch, Agriculture Canada, Ottawa, Ontario Canada K1A 0C6

ABSTRACT

Amounts of 25-hydroxycholecalciferol in plasma were measured in two groups (A and B) of lambs (Experiment 1) and in two groups (C and D) of wethers (Experiment 2). Groups A (eight lambs) and C (nine wethers) consisted of animals born and raised in total confinement; these animals exhibited an osteodystrophic condition. Groups B (four lambs) and D (10 wethers) consisted of healthy animals born and raised in a conventional barn with free access to an open barn yard (i.e. exposure to sunshine).

The 25-hydroxycholecalciferol in plasma of both groups of sick animals, Group A (12.9 ng/ml) and Group C (18.0 ng/ml), were lower than the amounts of the two corresponding groups of healthy animals, Group B (29.2 ng/ml) and Group D (32.5 ng/ml). Pharmacokinetic analysis of 25-hydroxycholecalciferol in affected lambs following intramuscular injection of 1,000,000 IU vitamin D₃ indicated that transport of vitamin D₃ from the site of injection to the liver and its metabolism to 25-hydroxycholecalciferol were rapid. Peak 25-hydroxycholecalciferol occurred at .6 wk, and half-life was 3.1 wk.

¹ Animal Research Institute (Contribution No. 777).

² Statistical Research Section, Engineering and Statistical Research Institute (Contribution No. 1–40).